Cyberattacks are on the rise and healthcare is a primary target. During an executive roundtable at Becker's 9th Annual Health IT + Digital Health + RCM Meeting, Nelson Carreira, CDW healthcare ...

"Since the March 2024 closure of HSHS hospitals in the Chippewa Valley, there has been an unmet need for emergency and inpatient hospital services," Aspirus President and CEO Matt Heywood said in a ...

Nick Rizley has been appointed COO of Tucson, Ariz.-based Northwest Healthcare. Mr. Rizley has experience in operational efficiency and process optimization, according to a Nov. 13 LinkedIn post from ...

A six-month shortage of cisplatin, a drug used in the treatment of head and neck cancer, resulted in a 16% total cost increase for practices in the U.S. Oncology Network, according to a study ...

Discover the new nursing school at AdventHealth University Tampa, offering specialized certificates and addressing Florida's nursing shortage. Learn more here.

Meet Liz Kirby, the new executive director for virtual care and rural initiatives at USA Health. Learn about her plans to improve access to care and address th ...

Children's Healthcare of Atlanta is partnering with the baseball team the Atlanta Braves to build a new park.

Meet Rick Metzger, BSN, the newly appointed CEO of USA Health Providence Hospital in Mobile, Ala. With 30 years of healthcare experience, he brings a steady fo ...

Bryan Stiltz has been appointed CEO of AdventHealth Medical Group in the health system's Rocky Mountain region. Mr. Stiltz will continue in his role as executive vice president of physician enterprise ...

Naples, Fla.-based NCH Healthcare System continues to receive donations for the system's $265 million heart institute, expected to open in 2027. The latest $5 million donation comes from the James M.

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

The GAO's findings highlight that while the FDA conducted 621 foreign and 444 domestic inspections in fiscal 2023, the total number of inspections was still 36% lower than pre-pandemic levels in 2019.